5Yu Y, Khan J , Khanna C, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprorein Six-1 as key metastatic regulators[ J]. Nat Med, 2004, 10(2) :175 - 181.
6Khanna C , Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis[ J]. Nat Med,2004, 10(2) :182-186.
7Moilanen J, Lassus H, Leminen A, et al. Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients[ J]. Gynecol Oncol,2003, 90(2): 273-281.
8Makitie T, Carpen O, Vaheri A, et al. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma[ J]. Invest Ophthalmol Vis Sci ,2001 ,42 (11):2442 -2449.
9Hefler L A, Conein N, Mineham D, et al. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma:a multieenter study. [J]. Cancer,2002, 94( 1 ) :125 - 130.
2Ishibashi Y, Matsumoto T, Niwa M, et al. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma[J]. Cancer, 2004,101(9):1994-2000.
3Martin T A, Harrison G, Mansel R E, et al. The role of the CD44/Ezrin complex in cancer metastasis[J]. Crit Rev Oncol Hematol, 2003,46(2):165-86.
4Kang Y K, Hong S W, Lee H, et al. Prognostic implications of ezri expression in human hepatocellular carcinoma[J]. Mol Carcinog, 2010,49(9):798-804.
5Xie J J, Xu L Y, Wu Z Y, et al. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma[J]. J Surg Oncol, 2011,104(5):538-43.
6Zhang X Q, Chen G P, Wu T, et al. Expression and clinical significance of ezrin in non-small-cell lung cancer[J]. Clin Lung Cancer, 2012,13(3):196-204.
7Roy R, Yang J, Moses M A. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer[J]. J Clin Oncol, 2009,27(31):5287-97.
8Al-Raawi D, Abu-El-Zahab H, El-Shinawi M, et al. Membrane type-1 matrix metalloproteinase(MT1-MMP)correlates with the expression and activation of matrixetalloproteinase-2(MMP-2)in inflammatory breast cancer[J]. Int J Clin Exp, 2011,4(4):265-75.
9Sato H, Takino T. Coordinate action of membrane-type matrix metalloproteinase-1(MT1-MMP)and MMP-2 enhances pericellular proteolysis and invasion[J]. Cancer Sci, 2010,101(4):843-7.
10Han K Y, Fahd D C, Tshionyi M, et al. MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts[J]. Protein Pept Lett, 2012,19(12):1334-49.
